GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » Cash-to-Debt

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Cash-to-Debt : 0.00 (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Pharmedic Pharmaceutical Medicinal Joint Stock Company's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Pharmedic Pharmaceutical Medicinal Joint Stock Company couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt or its related term are showing as below:

HSTC:PMC's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.93
* Ranked among companies with meaningful Cash-to-Debt only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Cash-to-Debt Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Cash-to-Debt Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Cash-to-Debt

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Cash-to-Debt

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012